Sign in
4

Changes in Ownership

Neurogene Inc. Filed Acc 0001209191-14-032925

Options or other derivatives

  • CFO, Vice President Finance acquired 31,250 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Alam Kamran · CFO, Vice President Finance

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2014-05-08 Grant or award : show line 1 in the form Stock Option (Right to Buy) +31,250 $10.10 2024-05-07 31,250 31,250 D
Loading xslF345X03/doc4.xml…